NEW YORK CITY (dpa-AFX) - Evotec AG (EVTCY.PK, EVOTF.PK) announced a
collaboration with Pfizer Inc. (PFE) to advance drug discovery efforts in
France.

As per the multi-year master research collaboration and option and license
agreement, the companies will initially focus on early discovery research for
metabolic and infectious diseases.

Evotec noted that the research will be carried out at its sites in France,
including
Campus Curie in Toulouse, a state-of-the-art research site with capabilities
spanning high throughput screening, in vitro and in vivo biology, proteomics and
metabolomics.

Evotec said it will receive research support funding from Pfizer and be eligible
for potential milestones and royalties related to success of the programs.



Copyright(c) 2024 RTTNews.com. All Rights Reserved

Copyright RTT News/dpa-AFX